- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Todd P. Davis
News 10 results
In the News · Source: Law360
January 15, 2020
Todd Davis counsels GSK in the first trial in a multidistrict case over the company's Zofran medication
In the News · Source: Global Legal Chronicle
In the News · Source: Law360 and Bloomberg Law
In the News · Source: Law360 and The American Lawyer
August 22, 2018
Andy Bayman, Todd Davis and Heather Howard obtain a dismissal before the Seventh Circuit for GSK in its appeal of a $3 million jury award
Cases & Deals
June 1, 2018
King & Spalding Obtains Two Dismissals on the Eve of Trial
Cases & Deals
April 20, 2017
K&S Team Holds Jury to Less Than One-Tenth of Plaintiff’s Requested Damages in Generic Paroxetine-Suicide Case
Cases & Deals
April 4, 2016
In Philadelphia Court of Common Pleas, King & Spalding Wins Trial on Directed Verdict
Cases & Deals
March 3, 2015
Fifth Circuit Affirms Summary Judgment Dismissal on Statute of Limitations
Recognition
June 6, 2011
King & Spalding Profile in Legal 500’s U.S. Guide Swells to 17 Practice and 55 Individual Rankings
Recognition · Source: Legal 500
June 29, 2009
King & Spalding Lawyers Receive 28 Rankings in 2009 U.S. Edition of Legal 500